10.50Open10.50Pre Close0 Volume3 Open Interest67.00Strike Price0.00Turnover134.62%IV1.43%PremiumDec 20, 2024Expiry Date9.41Intrinsic Value100Multiplier4DDays to Expiry1.09Extrinsic Value100Contract SizeAmericanOptions Type0.8459Delta0.0224Gamma7.38Leverage Ratio-0.3312Theta0.0058Rho6.24Eff Leverage0.0187Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet